Riesen W F, Imhof C, Sturzenegger E, Descoeudres C, Mordasini R, Oetliker O H
Schweiz Med Wochenschr. 1986 Jan 4;116(1):8-11.
Reduction of plasma cholesterol by extracorporeal immune elimination of low density lipoproteins (LDL) as an efficient approach to the treatment of familial hypercholesterolemia is described. LDL was removed from the plasma by immune adsorption on Sepharose-bound sheep antibodies against apo B, the protein fraction of LDL. To prevent the possibility of sensitization by the sheep antibodies, F(ab')2 fragments were used and the antibody containing Sepharose was underlaid by LDL containing Sepharose. Within a treatment time of 4 1/2-5 hours a reduction of the total plasma cholesterol by 70-80% was obtained. The mean reduction of the cholesterol concentration was more than 40% with a 14-day interval between two treatments. The concentration of other plasma proteins was not affected. The 11 treatments achieved so far were well tolerated and no side effects could be observed.
描述了通过体外免疫清除低密度脂蛋白(LDL)来降低血浆胆固醇,这是一种治疗家族性高胆固醇血症的有效方法。通过用结合在琼脂糖上的抗载脂蛋白B(LDL的蛋白质部分)的羊抗体进行免疫吸附,从血浆中去除LDL。为防止羊抗体致敏,使用了F(ab')2片段,且含抗体的琼脂糖下面放置含LDL的琼脂糖。在4.5至5小时的治疗时间内,血浆总胆固醇降低了70%至80%。两次治疗间隔14天时,胆固醇浓度平均降低超过40%。其他血浆蛋白的浓度未受影响。迄今为止进行的11次治疗耐受性良好,未观察到副作用。